Nurix Therapeutics, Inc. (NRIX): EBITDA
-$276.93M
Year ended 2025-11-30
-$352.58M
Trailing 12 months to 2026-05-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-11-30 | -$276.93M | n/m | 2026-01-28, From 2024-12-01 |
| 2024-11-30 | -$203.71M | n/m | 2026-01-28, From 2023-12-01 |
| 2023-11-30 | -$147.53M | n/m | 2026-01-28, From 2022-12-01 |
| 2022-11-30 | -$178.52M | n/m | 2025-01-28, From 2021-12-01 |
| 2021-11-30 | -$115.10M | n/m | 2023-02-09, From 2020-12-01 |
| 2020-11-30 | -$62.80M | n/m | 2022-01-28, From 2019-12-01 |
| 2019-11-30 | -$19.88M | n/a | 2022-01-28, From 2018-12-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | -$276.93M | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | -$178.08M | n/m |
| Standard Biotools Inc. (LAB) | 2025-12-31 | -$100.99M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$73.23M | n/m |
| Cytokinetics Inc (CYTK) | 2025-12-31 | -$602.13M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $3.20M | n/m |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $24.26M | -65.6% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$240.64M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$11.99M | n/m |
Compare NRIX, SPRY, LAB, ARCT side by side · Screen every company in Pharmaceutical Preparations ↗